Mettler-Toledo International Inc.

NYSE:MTD Stock Report

Market Cap: US$27.2b

Mettler-Toledo International Valuation

Is MTD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MTD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
US$1.03k
Fair Value
28.8% overvalued intrinsic discount
11
Number of Analysts

Below Fair Value: MTD ($1321.45) is trading above our estimate of fair value ($1026.32)

Significantly Below Fair Value: MTD is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MTD?

Key metric: As MTD is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MTD. This is calculated by dividing MTD's market cap by their current earnings.
What is MTD's PE Ratio?
PE Ratio32.8x
EarningsUS$829.75m
Market CapUS$27.22b

Price to Earnings Ratio vs Peers

How does MTD's PE Ratio compare to its peers?

The above table shows the PE ratio for MTD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average29.9x
A Agilent Technologies
29.6x10.73%US$34.6b
IQV IQVIA Holdings
26.3x13.22%US$32.5b
WAT Waters
27.2x10.94%US$18.0b
WST West Pharmaceutical Services
36.5x11.54%US$17.8b
MTD Mettler-Toledo International
32.8x7.58%US$27.2b

Price-To-Earnings vs Peers: MTD is expensive based on its Price-To-Earnings Ratio (32.8x) compared to the peer average (29.9x).

Price to Earnings Ratio vs Industry

How does MTD's PE Ratio compare vs other companies in the US Life Sciences Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
APDN Applied DNA Sciences
0.1x-96.42%US$4.49m
No more companies available in this PE range
MTD 32.8xIndustry Avg. 29.6xNo. of Companies4PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: MTD is expensive based on its Price-To-Earnings Ratio (32.8x) compared to the US Life Sciences industry average (29.6x).

Price to Earnings Ratio vs Fair Ratio

What is MTD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MTD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio32.8x
Fair PE Ratio19.6x

Price-To-Earnings vs Fair Ratio: MTD is expensive based on its Price-To-Earnings Ratio (32.8x) compared to the estimated Fair Price-To-Earnings Ratio (19.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MTD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$1,321.45
US$1,294.55
-2.04%
9.74%US$1,600.00US$1,150.00n/a11
Aug ’26US$1,197.23
US$1,276.36
+6.61%
7.05%US$1,450.00US$1,150.00n/a11
Jul ’26US$1,205.29
US$1,253.43
+3.99%
8.04%US$1,450.00US$1,110.00n/a12
Jun ’26US$1,155.52
US$1,245.38
+7.78%
7.92%US$1,450.00US$1,110.00n/a12
May ’26US$1,056.58
US$1,289.13
+22.01%
10.91%US$1,530.00US$1,034.00n/a12
Apr ’26US$1,156.38
US$1,369.55
+18.43%
8.36%US$1,530.00US$1,120.00n/a12
Mar ’26US$1,272.72
US$1,370.76
+7.70%
8.75%US$1,530.00US$1,120.00n/a12
Feb ’26US$1,364.44
US$1,343.51
-1.53%
8.37%US$1,500.00US$1,150.00n/a12
Jan ’26US$1,223.68
US$1,334.18
+9.03%
8.10%US$1,500.00US$1,150.00n/a12
Dec ’25US$1,251.20
US$1,327.93
+6.13%
8.36%US$1,500.00US$1,175.00n/a12
Nov ’25US$1,342.09
US$1,382.51
+3.01%
9.85%US$1,600.00US$1,200.00n/a12
Oct ’25US$1,477.64
US$1,380.43
-6.58%
9.64%US$1,580.00US$1,200.00n/a12
Sep ’25US$1,439.08
US$1,382.00
-3.97%
9.17%US$1,580.00US$1,200.00n/a12
Aug ’25US$1,515.35
US$1,365.82
-9.87%
9.69%US$1,590.00US$1,200.00US$1,197.2311
Jul ’25US$1,366.84
US$1,350.82
-1.17%
10.75%US$1,590.00US$1,150.00US$1,205.2911
Jun ’25US$1,404.09
US$1,317.00
-6.20%
15.63%US$1,590.00US$880.00US$1,155.5210
May ’25US$1,249.75
US$1,188.73
-4.88%
12.28%US$1,360.00US$880.00US$1,056.5811
Apr ’25US$1,341.20
US$1,177.82
-12.18%
12.01%US$1,360.00US$880.00US$1,156.3811
Mar ’25US$1,267.98
US$1,177.82
-7.11%
12.01%US$1,360.00US$880.00US$1,272.7211
Feb ’25US$1,224.00
US$1,148.04
-6.21%
14.23%US$1,491.40US$880.00US$1,364.4411
Jan ’25US$1,212.96
US$1,121.20
-7.56%
14.76%US$1,491.40US$880.00US$1,223.6812
Dec ’24US$1,104.47
US$1,114.00
+0.86%
13.60%US$1,450.00US$880.00US$1,251.2012
Nov ’24US$969.48
US$1,243.00
+28.21%
16.09%US$1,521.00US$880.00US$1,342.0912
Oct ’24US$1,108.07
US$1,323.50
+19.44%
12.55%US$1,521.00US$880.00US$1,477.6412
Sep ’24US$1,222.50
US$1,323.50
+8.26%
12.55%US$1,521.00US$880.00US$1,439.0812
Aug ’24US$1,284.43
US$1,323.50
+3.04%
12.55%US$1,521.00US$880.00US$1,515.3512
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
US$1.29k
Fair Value
2.1% overvalued intrinsic discount
11
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/24 00:07
End of Day Share Price 2025/08/22 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mettler-Toledo International Inc. is covered by 29 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Ishan MajumdarBaptista Research
Luke SergottBarclays